| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:32721735 |
| GO:0001541 | Ovarian follicle development | Affects phenotype | PMID:34383603 |
| GO:0001547 | Antral ovarian follicle growth | Affects phenotype | PMID:34383603 |
| GO:0001552 | Ovarian follicle atresia | Affects phenotype | PMID:34383603 |
| GO:0002021 | Response to dietary excess | Decreases phenotype | PMID:31022254 |
| GO:0002377 | Immunoglobulin production | Affects phenotype | PMID:15831097 |
| GO:0002449 | Lymphocyte mediated immunity | Affects phenotype | PMID:15831097 |
| GO:0004177 | Aminopeptidase activity | Increases phenotype | PMID:34225579 |
| GO:0004364 | Glutathione transferase activity | Increases phenotype | PMID:29554563 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:29481894; PMID:32721735 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:29481894 |
| GO:0006119 | Oxidative phosphorylation | Increases phenotype | PMID:34311058 |
| GO:0006304 | Dna modification | Decreases phenotype | PMID:28659405 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:20064773; PMID:23933504 |
| GO:0006325 | Chromatin organization | Affects phenotype | PMID:15687046 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:31022254 |
| GO:0006783 | Heme biosynthetic process | Affects phenotype | PMID:18941586 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:15820723; PMID:24576310 |
| GO:0006959 | Humoral immune response | Affects phenotype | PMID:15831097 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:15820723; PMID:25386960 |
| GO:0007005 | Mitochondrion organization | Increases phenotype | PMID:34311058 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:29554563 |
| GO:0007281 | Germ cell development | Affects phenotype | PMID:34383603 |
| GO:0007283 | Spermatogenesis | Affects phenotype | PMID:15687046; PMID:34000504 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:25410718; PMID:30153481 |
| GO:0007565 | Female pregnancy | Decreases phenotype | PMID:30153481 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:19165398 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:28392238 |
| GO:0008219 | Cell death | Increases phenotype | PMID:30075218 |
| GO:0008234 | Cysteine-type peptidase activity | Decreases phenotype | PMID:35563431 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:17599374; PMID:23501609; PMID:23913582; PMID:24576310 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:25263748; PMID:28412309 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:28572628; PMID:29149346 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:34000504 |
| GO:0008637 | Apoptotic mitochondrial changes | Increases phenotype | PMID:25410718 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:38294233 |
| GO:0010467 | Gene expression | Affects phenotype | PMID:25386960 |
| GO:0010822 | Positive regulation of mitochondrion organization | Decreases phenotype | PMID:28397872 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:31022254 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:26200599 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Affects phenotype | PMID:28397872; PMID:34311058 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:26563996 |
| GO:0015747 | Urate transport | Increases phenotype | PMID:28572628 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:29481894 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:23913582; PMID:33571556 |
| GO:0019217 | Regulation of fatty acid metabolic process | Affects phenotype | PMID:28397872 |
| GO:0019254 | Carnitine metabolic process, coa-linked | Increases phenotype | PMID:31022254 |
| GO:0019646 | Aerobic electron transport chain | Decreases phenotype | PMID:28397872 |
| GO:0019766 | Iga receptor activity | Decreases phenotype | PMID:26649893 |
| GO:0019770 | Igg receptor activity | Decreases phenotype | PMID:26649893 |
| GO:0022602 | Ovulation cycle process | Affects phenotype | PMID:16299097 |
| GO:0023056 | Positive regulation of signaling | Affects phenotype | PMID:25386960 |
| GO:0030264 | Nuclear fragmentation involved in apoptotic nuclear change | Increases phenotype | PMID:26563996 |
| GO:0030539 | Male genitalia development | Affects phenotype | PMID:34000504 |
| GO:0031959 | Mineralocorticoid receptor signaling pathway | Increases phenotype | PMID:29149346 |
| GO:0032000 | Positive regulation of fatty acid beta-oxidation | Increases phenotype | PMID:31022254 |
| GO:0032109 | Positive regulation of response to nutrient levels | Increases phenotype | PMID:28572628 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:26022396 |
| GO:0033993 | Response to lipid | Decreases phenotype | PMID:28659405 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:30575243; PMID:30575243; PMID:31022254; PMID:31022254 |
| GO:0035064 | Methylated histone binding | Affects phenotype | PMID:34383603 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:32518293 |
| GO:0036269 | Swimming behavior | Affects phenotype | PMID:32518293 |
| GO:0036343 | Psychomotor behavior | Affects phenotype | PMID:17431495 |
| GO:0040007 | Growth | Increases phenotype | PMID:23963708 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:19750101 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:31022254 |
| GO:0042696 | Menarche | Affects phenotype | PMID:16299097 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:34311058 |
| GO:0042711 | Maternal behavior | Affects phenotype | PMID:34383603 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:25410718 |
| GO:0043433 | Negative regulation of dna-binding transcription factor activity | Increases phenotype | PMID:26022396 |
| GO:0043970 | Histone h3-k9 acetylation | Affects phenotype | PMID:34383603 |
| GO:0044028 | Dna hypomethylation | Increases phenotype | PMID:26563996 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:31272017 |
| GO:0044065 | Regulation of respiratory system process | Decreases phenotype | PMID:31362153 |
| GO:0044127 | Regulation of development of symbiont in host | Affects phenotype | PMID:28392238 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:34311058; PMID:35457000; PMID:36613676; PMID:36674557 |
| GO:0044849 | Estrous cycle | Affects phenotype | PMID:34383603 |
| GO:0045019 | Negative regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:37236336 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:26200599 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:34311058 |
| GO:0046323 | Glucose import | Decreases phenotype | PMID:34311058 |
| GO:0046470 | Phosphatidylcholine metabolic process | Affects phenotype | PMID:38048832 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:32518293 |
| GO:0046722 | Lactic acid secretion | Increases phenotype | PMID:28572628 |
| GO:0048135 | Female germ-line cyst formation | Affects phenotype | PMID:34383603 |
| GO:0048386 | Positive regulation of retinoic acid receptor signaling pathway | Increases phenotype | PMID:26563996 |
| GO:0048589 | Developmental growth | Increases phenotype | PMID:25014249; PMID:25095280; PMID:25742056 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Decreases phenotype | PMID:28659405 |
| GO:0050847 | Progesterone receptor signaling pathway | Decreases phenotype | PMID:26022396 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:16818570; PMID:26414943 |
| GO:0051308 | Male meiosis chromosome separation | Affects phenotype | PMID:26535963 |
| GO:0055064 | Chloride ion homeostasis | Decreases phenotype | PMID:28572628 |
| GO:0055078 | Sodium ion homeostasis | Decreases phenotype | PMID:28572628 |
| GO:0060207 | Diestrus | Affects phenotype | PMID:34383603 |
| GO:0060208 | Proestrus | Affects phenotype | PMID:34383603 |
| GO:0060209 | Estrus | Affects phenotype | PMID:34383603 |
| GO:0060322 | Head development | Affects phenotype | PMID:25014249 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:33571556 |
| GO:0061028 | Establishment of endothelial barrier | Decreases phenotype | PMID:33571556 |
| GO:0061078 | Positive regulation of prostaglandin secretion involved in immune response | Increases phenotype | PMID:26748080 |
| GO:0061179 | Negative regulation of insulin secretion involved in cellular response to glucose stimulus | Increases phenotype | PMID:28867213 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:34000504 |
| GO:0061458 | Reproductive system development | Affects phenotype | PMID:34000504 |
| GO:0061517 | Macrophage proliferation | Affects phenotype | PMID:26748080 |
| GO:0061519 | Macrophage homeostasis | Affects phenotype | PMID:26748080 |
| GO:0061628 | H3k27me3 modified histone binding | Affects phenotype | PMID:34383603 |
| GO:0070091 | Glucagon secretion | Affects phenotype | PMID:36613676; PMID:36674557 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:31022254 |
| GO:0070577 | Lysine-acetylated histone binding | Affects phenotype | PMID:34383603 |
| GO:0071514 | Genomic imprinting | Affects phenotype | PMID:30153481 |
| GO:0080182 | Histone h3-k4 trimethylation | Affects phenotype | PMID:34383603; PMID:38294233 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:32518293 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30153481 |
| GO:0098532 | Histone h3-k27 trimethylation | Affects phenotype | PMID:34383603 |
| GO:0120041 | Positive regulation of macrophage proliferation | Increases phenotype | PMID:31022254 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:28397872; PMID:30575243; PMID:38092172; PMID:39778647 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Affects phenotype | PMID:25410718; PMID:31022254 |
| GO:1902093 | Positive regulation of flagellated sperm motility | Decreases phenotype | PMID:25410718 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:25263748; PMID:25410718; PMID:30575243; PMID:30575243; PMID:31022254 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:28273962 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:25263748; PMID:37236336 |
| GO:1903788 | Positive regulation of glutathione biosynthetic process | Decreases phenotype | PMID:25263748 |
| GO:1904179 | Positive regulation of adipose tissue development | Increases phenotype | PMID:31022254 |
| GO:1905867 | Epididymis development | Affects phenotype | PMID:34000504 |
| GO:2000077 | Negative regulation of type b pancreatic cell development | Increases phenotype | PMID:28867213 |
| GO:2000439 | Positive regulation of monocyte extravasation | Increases phenotype | PMID:26748080 |
| GO:2000609 | Regulation of thyroid hormone generation | Affects phenotype | PMID:25965908 |
| GO:2000612 | Regulation of thyroid-stimulating hormone secretion | Affects phenotype | PMID:19750101 |
| GO:2001171 | Positive regulation of atp biosynthetic process | Decreases phenotype | PMID:28397872 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.